Dr. Nicholson graduated from the University of Alabama School of Medicine in 1986. He works in Edina, MN and 2 other locations and specializes in General Surgery and Vascular Surgery. Dr. Nicholson is affiliated with Fairview Ridges Hospital and Fairview Southdale Hospital.
Aug 2011 to 2000 General Chemistry Laboratory Section Supervisor / Teaching AssistantORTHOVITA / STRYKER ORTHOBIOLOGICS Malvern, PA Jul 2007 to Jul 2011 Quality BiochemistWEST PHARMACEUTICAL SERVICES Lionville, PA Mar 2003 to Jul 2007 Associate Chemist
Education:
The Catholic University of America Washington, DC May 2002 Bachelor of Science in Biochemistry
John S. C. Chiang - Mercerville NJ Charles J. Nicholson - New Hope PA
Assignee:
FMC Corporation - Philadelphia PA
International Classification:
G25B 1112
US Classification:
204294
Abstract:
The invention is a porous gas diffusion electrode suitable for manufacturing hydrogen peroxide by the reduction of oxygen in an alkaline electrolyte and of a process for fabricating the electrode.
Tunable, Controlled-Release, Urethane-Containing Elastomers And Processes Of Forming The Same
- Telford PA, US Carissa Smoot - Harleysville PA, US Dennis Shull - Phoenixville PA, US Todd Crumbling - Perkasie PA, US John D'Ottavio - Telford PA, US Peter D. Gabriele - Frisco TX, US Jeremy J. Harris - Doylestown PA, US Charles Brendan Nicholson - Coopersburg PA, US Jared Ely - Quakertown PA, US
A process forms an implantable product including poly(glycerol sebacate) urethane (PGSU) loaded with an active pharmaceutical ingredient (API). The process includes homogeneously mixing a flowable poly(glycerol sebacate) (PGS) resin with the API and a catalyst to form a resin blend. The process also includes homogeneously combining the resin blend with an isocyanate to form a reaction mixture and injecting the reaction mixture to form the PGSU loaded with the API. An implantable product includes a PGSU loaded with an API. In some embodiments, the implantable product includes at least 40% w/w of the API, and the implantable product releases the API by surface degradation of the PGSU at a predetermined release rate for at least three months under physiological conditions. In some embodiments, the PGSU is formed from a PGS reacted with an isocyanate at an isocyanate-to-hydroxyl stoichiometric (crosslinking) ratio in the range of 1:0.25 to 1:1.25.
Tunable, Controlled-Release, Urethane-Containing Elastomers And Processes Of Forming The Same
- Telford PA, US Carissa SMOOT - Harleysville PA, US Dennis SHULL - Phoenixville PA, US Todd CRUMBLING - Perkasie PA, US John D'OTTAVIO - Telford PA, US Peter D. GABRIELE - Frisco TX, US Jeremy J. HARRIS - Doylestown PA, US Charles Brendan NICHOLSON - Coopersburg PA, US Jared ELY - Quakertown PA, US
A process forms an implantable product including poly(glycerol sebacate) urethane (PGSU) loaded with an active pharmaceutical ingredient (API). The process includes homogeneously mixing a flowable poly(glycerol sebacate) (PGS) resin with the API and a catalyst to form a resin blend. The process also includes homogeneously combining the resin blend with an isocyanate to form a reaction mixture and injecting the reaction mixture to form the PGSU loaded with the API. An implantable product includes a PGSU loaded with an API. In some embodiments, the implantable product includes at least 40% w/w of the API, and the implantable product releases the API by surface degradation of the PGSU at a predetermined release rate for at least three months under physiological conditions. In some embodiments, the PGSU is formed from a PGS reacted with an isocyanate at an isocyanate-to-hydroxyl stoichiometric (crosslinking) ratio in the range of 1:0.25 to 1:1.25.
Poly(Glycerol Sebacate)-Interleukin Inhibitor Copolymers And Methods Of Making And Use
A method includes combining an alcohol-pharmaceutical conjugate, a polyol, and an aqueous liquid in a vessel. The alcohol-pharmaceutical conjugate includes a pharmaceutical compound having at least one carboxyl group attached to the polyol by an ester bond. The method also includes adding an acid monomer to the vessel and heating and removing water from the vessel to produce the polymeric material. The polymeric material includes a polyester copolymer of the acid monomer and the polyol and the pharmaceutical compound.
- Telford PA, US Carissa SMOOT - Harleysville PA, US Peter D. GABRIELE - Frisco TX, US Jeremy J. HARRIS - Doylestown PA, US Charles Brendan NICHOLSON - Coopersburg PA, US Steven LU - Cambridge MA, US
A filler material of a thermoset resin of a diacid/polyol, such as PGS is provided. The filler useful in forming composites, such as those in which the filler and a resin matrix are of the same material to provide a homogenous polymeric composition. Composites in which at least one of the matrix, the filler or both are PGS are also provided. Methods of forming such filler materials and composites are also disclosed. The composites allow extrusion process to form articles from materials that would not otherwise be capable of being extruded.
Tunable, Controlled-Release, Urethane-Containing Elastomers And Processes Of Forming The Same
- Telford PA, US Carissa SMOOT - Harleysville PA, US Dennis SHULL - Phoenixville PA, US Todd CRUMBLING - Perkasie PA, US John D'OTTAVIO - Telford PA, US Peter D. GABRIELE - Frisco TX, US Jeremy J. HARRIS - Doylestown PA, US Charles Brendan NICHOLSON - Coopersburg PA, US Jared ELY - Quakertown PA, US
A process forms an implantable product including poly(glycerol sebacate) urethane (PGSU) loaded with an active pharmaceutical ingredient (API). The process includes homogeneously mixing a flowable poly(glycerol sebacate) (PGS) resin with the API and a catalyst to form a resin blend. The process also includes homogeneously combining the resin blend with an isocyanate to form a reaction mixture and injecting the reaction mixture to form the PGSU loaded with the API. An implantable product includes a PGSU loaded with an API. In some embodiments, the implantable product includes at least 40% w/w of the API, and the implantable product releases the API by surface degradation of the PGSU at a predetermined release rate for at least three months under physiological conditions. In some embodiments, the PGSU is formed from a PGS reacted with an isocyanate at an isocyanate-to-hydroxyl stoichiometric (crosslinking) ratio in the range of 1:0.25 to 1:1.25.
Poly(Glycerol Sebacate)-Interleukin Inhibitor Copolymers And Methods Of Making And Use
- Telford PA, US Carissa SMOOT - Harleysville PA, US Charles Brendan NICHOLSON - Coopersburg PA, US Jeremy J. HARRIS - Buckingham PA, US
International Classification:
C08G 63/12 C08G 63/06 C08G 63/78
Abstract:
A method includes combining an alcohol-pharmaceutical conjugate, a polyol, and an aqueous liquid in a vessel. The alcohol-pharmaceutical conjugate includes a pharmaceutical compound having at least one carboxyl group attached to the polyol by an ester bond. The method also includes adding an acid monomer to the vessel and heating and removing water from the vessel to produce the polymeric material. The polymeric material includes a polyester copolymer of the acid monomer and the polyol and the pharmaceutical compound.
- Telford PA, US Carissa SMOOT - Harleysville PA, US Peter D. GABRIELE - Frisco TX, US Jeremy J. HARRIS - Buckingham PA, US Charles Brendan NICHOLSON - Coopersburg PA, US Steven LU - Ambler PA, US
International Classification:
A61K 47/48 A61K 47/34 C08G 63/12
Abstract:
A filler material of a thermoset resin of a diacid/polyol, such as PGS is provided. The filler useful in forming composites, such as those in which the filler and a resin matrix are of the same material to provide a homogenous polymeric composition. Composites in which at least one of the matrix, the filler or both are PGS are also provided. Methods of forming such filler materials and composites are also disclosed. The composites allow extrusion process to form articles from materials that would not otherwise be capable of being extruded.
News
Woman kidnapped by triple murder suspect convinces him to surrender
Oen Nicholson, 30, will be extradited back to Oregon where he faces three murder charges for the deadly rampage that began Friday when he allegedly killed his father, Charles Nicholson, at an RV campground in the coastal city of North Bend, police said.